New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Immune therapy reduces risk of recurrence in aggressive breast cancer

Immune therapy reduces risk of recurrence in aggressive breast cancer

byQueen Mary, University of LondonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by
World medicine December 11,2023
Immune therapy reduces risk of recurrence in aggressive breast cancer

Immune therapy reduces risk of recurrence in aggressive breast cancer

byQueen Mary, University of LondonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by
World medicine December 11,2023
Targeting stromal cells may help overcome treatment resistance in glioblastoma

Targeting stromal cells may help overcome treatment resistance in glioblastoma

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0The deadly brain cancer glioblastoma (GBM) is often resistant to chem
World medicine December 11,2023
Targeting stromal cells may help overcome treatment resistance in glioblastoma

Targeting stromal cells may help overcome treatment resistance in glioblastoma

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0The deadly brain cancer glioblastoma (GBM) is often resistant to chem
World medicine December 11,2023
New imaging technique enables the study of 3-D printed brain tumors

New imaging technique enables the study of 3-D printed brain tumors

byRensselaer Polytechnic InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastomas are complex, fast-growing malignant brain tumors that are made up of various types o
World medicine December 11,2023
New imaging technique enables the study of 3-D printed brain tumors

New imaging technique enables the study of 3-D printed brain tumors

byRensselaer Polytechnic InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastomas are complex, fast-growing malignant brain tumors that are made up of various types o
World medicine December 11,2023
Chimeras offer a new way to study childhood cancers in mice

Chimeras offer a new way to study childhood cancers in mice

byWhitehead Institute for Biomedical ResearchA slice of a neuroblastoma tumor derived from chimeric mice stained by immunofluorescence for human neuroblastoma markers. Credit: Whitehead Institut
World medicine December 11,2023
Chimeras offer a new way to study childhood cancers in mice

Chimeras offer a new way to study childhood cancers in mice

byWhitehead Institute for Biomedical ResearchA slice of a neuroblastoma tumor derived from chimeric mice stained by immunofluorescence for human neuroblastoma markers. Credit: Whitehead Institut
World medicine December 11,2023
U.S. life expectancy goes up as cancer deaths go down

U.S. life expectancy goes up as cancer deaths go down

by Alvin Powell,Harvard UniversityProfessor Timothy Rebbeck looks at the reduction in deaths from cancer, the nation’s No. 2 killer. Credit: Kris Snibbe/Harvard Staff PhotographerU.S. life expec
World medicine December 11,2023
U.S. life expectancy goes up as cancer deaths go down

U.S. life expectancy goes up as cancer deaths go down

by Alvin Powell,Harvard UniversityProfessor Timothy Rebbeck looks at the reduction in deaths from cancer, the nation’s No. 2 killer. Credit: Kris Snibbe/Harvard Staff PhotographerU.S. life expec
World medicine December 11,2023
Colorectal cancer burden shifting to younger individuals

Colorectal cancer burden shifting to younger individuals

byAmerican Cancer SocietyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The burden of colorectal cancer is swiftly shifting to younger individuals as incidence
World medicine December 11,2023
Colorectal cancer burden shifting to younger individuals

Colorectal cancer burden shifting to younger individuals

byAmerican Cancer SocietyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The burden of colorectal cancer is swiftly shifting to younger individuals as incidence
World medicine December 11,2023
Colorectal cancer partner-in-crime identified

Colorectal cancer partner-in-crime identified

byHokkaido UniversityTumorigenesis of colorectal cancer cells (CT26, red) were significantly reduced in mice liver tissue lacking IL-6 (Il6-/-), suggesting IL-6's supportive function on meta
World medicine December 11,2023
Colorectal cancer partner-in-crime identified

Colorectal cancer partner-in-crime identified

byHokkaido UniversityTumorigenesis of colorectal cancer cells (CT26, red) were significantly reduced in mice liver tissue lacking IL-6 (Il6-/-), suggesting IL-6's supportive function on meta
World medicine December 11,2023
Treatment for hereditary breast cancer not always guideline-concordant

Treatment for hereditary breast cancer not always guideline-concordant

(HealthDay)—Many women with early-stage breast cancer who test positive for an inherited genetic variant are receiving cancer treatment that does not follow current guidelines, according to a study pu
World medicine December 11,2023
Treatment for hereditary breast cancer not always guideline-concordant

Treatment for hereditary breast cancer not always guideline-concordant

(HealthDay)—Many women with early-stage breast cancer who test positive for an inherited genetic variant are receiving cancer treatment that does not follow current guidelines, according to a study pu
World medicine December 11,2023
Number of cancer cases in Canada will increase in 2020 as population ages

Number of cancer cases in Canada will increase in 2020 as population ages

byCanadian Medical Association JournalCredit: CC0 Public DomainAs Canada's population grows and ages, the cancer burden will remain high and even increase in 2020, according to a study on pr
World medicine December 11,2023
Number of cancer cases in Canada will increase in 2020 as population ages

Number of cancer cases in Canada will increase in 2020 as population ages

byCanadian Medical Association JournalCredit: CC0 Public DomainAs Canada's population grows and ages, the cancer burden will remain high and even increase in 2020, according to a study on pr
World medicine December 11,2023
Newly discovered immune cell type may be key to improving pancreatic cancer immunotherapy

Newly discovered immune cell type may be key to improving pancreatic cancer immunotherapy

by Jim Stallard,Memorial Sloan Kettering Cancer CenterImmunotherapies have succeeded by enabling immune T cells (orange) to destroy cancer cells (yellow). Researchers have found that targeting a
World medicine December 11,2023
Newly discovered immune cell type may be key to improving pancreatic cancer immunotherapy

Newly discovered immune cell type may be key to improving pancreatic cancer immunotherapy

by Jim Stallard,Memorial Sloan Kettering Cancer CenterImmunotherapies have succeeded by enabling immune T cells (orange) to destroy cancer cells (yellow). Researchers have found that targeting a
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com